Brief: Klaria Pharma Q4 Loss After Tax Narrows To SEK 5.3 Mln
Feb 28 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* KLARIA PHARMA HOLDING YEAR-END REPORT
* Q4 NET SALES AMOUNTED TO 0.2 MSEK (0.0 MSEK)
* Q4 PROFIT AFTER TAX AMOUNTED TO -5.3 MSEK (-8.1 MSEK)
Source text for Eikon: ID:nWkr87KzTy
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement